Hereditary Amyloidosis Market With CAGR of 11.8% by 2031 Market Size & Share Insight | Pfizer Inc, Ionis Pharmaceuticals
Hereditary amyloidosis market is estimated to be valued at USD 1.23 Bn in 2024 and will reach USD 2.7 Bn by 2031, growing at a CAGR of 11.8% from 2024 to 2031. BURLINGAME, CA, UNITED STATES, December 24, 2024 /EINPresswire.com/ -- According to a …